-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2024.
- NEUROONE MEDICAL TECHNOLOGIES Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $1.21M.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $7.27M, a 1.75% decline from 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7.4M, a 38.5% decline from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $12M, a 4.23% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)